I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

I am a healthcare professional in Spain

Required field.

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience ECTRIMS 2025
Roche and Genentech at

ECTRIMS 2025

September 24 - September 26
Barcelona, Spain / Virtual (Hybrid)
ectrims.eu
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
06:30 AM
Duration 120mins Barcelona, Spain
Characteristics of Patients Starting Ocrelizumab Subcutaneous in Denmark, Germany, and the United Kingdom
Braune, Stefan; Ingram, Gillian; Sellebjerg, Finn; Christensen, Jeppe Romme; Rasmussen, Peter Vestergaard; Jensen, Henrik Boye; Prakash, Sivagini; Bergmann, Arnfin; Witts, James A; Pearson, Owen; Middleton, Rod; Jarecki, Jana B; Heer, Yanic; Ferro, Ana; Acosta, Juan; Magyari, Melinda
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Barcelona, Spain
Symptoms related to lower and upper limb function frequently impact daily activities in people with multiple sclerosis
Mclver, Tammy; Davies, Evan; Galactionova, Katya; Fisher, Kathryn; Dolan, Chantal; Durand-Zaleski, Isabelle; Clinch, Susanne
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Barcelona, Spain
A 20% change in the Timed 25-Foot Walk Test and 9-Hole Peg Test is clinically meaningful
Mclver, Tammy; Galactionova, Katya; Fisher, Kathryn; Dolan, Chantal; Tumani, Hayrettin; Mantovani, Lorenzo; Davies, Evan
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Barcelona, Spain
Associations Between Comorbidities, Disease Activity and Response to Ocrelizumab in the CHIMES Trial
Reder, Anthony; Wu, Gregory; Okai, Annette; Chinea, Angel; Sokhi, Dilraj Singh; Williams, Mitzi; Vartanian, Tim; Bernitsas, Evanthia; Monson, Nancy; Khatri, Bhupendra; Amjad, Faria; Goldstick, Lawrence; Jones, David: Pei, Jinglan; Clayton, David; Smith, Jugena; Abioye, Ibraheem; Amezcua, Lilyana
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Barcelona, Spain
Understanding the Experiences of Neurologists Treating Women with MS and their Perspectives about Family Planning with MS in Europe and the United States
Seetasith, Arpamas; Pasquarelli, Noemi; Muros, Erwan; Johnson, Will; Unsworth, Mia; Pineda, Elmor D.
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Barcelona, Spain
Integrating multicentre data to explore rwPIRMA: Results from the INTONATE-MS consortium
Oh, Jiwon; Smolders, Joost; Buijs, Frederik; Federer-Gsponer, Joel; Meyer zu Hörste, Gerd; Mamdani, Muhammad; Perrone, Christopher; Mowery, Danielle L; Kühnel, Timm; van Tulder, Koen; Testa, Carolina; Elze, Marcus C; Pedotti, Rosetta; Kaczmarek, Lukasz; Sharma, Vishakha; Tackenberg, Björn; Bar-Or, Amit; Wiendl, Heinz
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 10hrs Barcelona, Spain
Device bridging study demonstrates bioequivalence for 180 mg satralizumab▼given subcutaneously using prefilled syringe and autoinjector
Lottie Rayburn; Subramanian Ganesasundararajan; Muna El-Khairi; Hanna Silber Baumann; Jean-Christophe Genin; Alexander Burdeska; Hayley Bostock; Ivana Vodopivec; Sian Lennon-Chrimes
Neuroscience | Neuromyelitis Optica Spectrum Disorder

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
02:30 PM
Duration 120mins Barcelona, Spain
Maternal and infant pregnancy outcomes in women with MS who received ocrelizumab versus a comparator MS population: results of the Ocrelizumab Pregnancy Registry
Hellwig, Kerstin; Ferreira, Germano; Pacheco Duran, Gonzalo; Alves, Daniela; Pasquarelli, Noemi; Houtchens, Maria
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Barcelona, Spain
MANUSCRIPT: long-term surveillance of ocrelizumab-treated patients with multiple sclerosis interim comparative safety analysis
Butzkueven, Helmut; Buttman, Mathias; Duran-Pacheco, Gonzalo Christian; El Azouzzi, Bouchra; Elberling, Frederik; Ferreira, Germano; Flavia Mouresan, Elena; Glaser, Anna; Hillert, Jan; Iaffaldano, Pietro; Lucisano, Giuseppe; Muros-Le Rouzic, Erwan; Rollot, Fabien; Trojano, Maria; Vukusic, Sandra; Zhu, Chao; Ziemssen, Tjalf; Magyari, Melinda
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Barcelona, Spain
Ocrelizumab subcutaneous: final analysis of the OCARINA II study
Newsome, Scott D; Goldstick, Lawrence; Selmaj, Krzysztof; Krzystanek, Eva; Zecevic, Dusanka; Clinch, Susanne; Giacobino, Caroline; Azmi, Jay; Figueiredo, Catarina; Centonze, Diego
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Barcelona, Spain
Safety and effectiveness of satralizumab▼ in Japanese patients with neuromyelitis optica spectrum disorder: A 30 month interim analysis of large-scale post marketing surveillance
Takashi Yamamura, Noriko Isobe, Izumi Kawachi, Chiyoko Nohara, Yusei Miyazaki, Minami Tomita, Yuta Kamei, Katsuhisa Yamashita, Jin Nakahara, Ichiro Nakashima, Kazuo Fujihara
Neuroscience | Neuromyelitis Optica Spectrum Disorder

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
12:35 PM
Duration 10mins Lecture Hall 211
Humoral Responses and 1-Year Follow Up of Infants Potentially Exposed to Ocrelizumab During Pregnancy and Breastfeeding: Final Analysis of the Prospective, Multicentre, Open-Label, Phase IV Studies MINORE and SOPRANINO
Bove, Riley; Hellwig, Kerstin; Dobson, Ruth; Oreja-Guevara, Celia; Derfuss, Tobias; Shah, Anna; Graham, Edith L; McElrath, Thomas; Pietrasanta, Carlo; Maillart, Elisabeth; Jacobs, Dina; Kazlauskaite, Agne; Alves, Daniela; Raposo, Catarina; Craveiro, Licinio; Lin, Chien-Ju; Pasquarelli, Noemi; Vukusic, Sandra
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:15 PM
Duration 10mins Lecture Hall 211
Ocrelizumab Dose Selection for Treatment of Paediatric Relapsing-Remitting Multiple Sclerosis: Long-Term 96-Week Safety and Efficacy Results of the Phase II OPERETTA 1 Study
Waubant, Emmanuelle; Kotulska, Katarzyna; Valeriani, Massimiliano; Mar, Soe; Steinborn, Barbara; Schreiner, Teri; Filippi, Massimo; Mazurkiewicz-Beldzinska, Maria; Hennika, Tammy; Campos, Norodom; Lin, Chien-Ju; El-Azzouzi, Bouchra; Banwell, Brenda
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
02:30 PM
Duration 120mins Barcelona, Spain
Real-World Patterns of Ocrelizumab and Other Disease-Modifying Therapy Utilization Before, During and After Pregnancy in Women with Multiple Sclerosis: A Retrospective Claims-Based Cohort Study
Houtchens, Maria K.; Miller, Alexandra; Sheinson, Danny; Xia, Zhiyu; Pasquarelli, Noemi; Muros, Erwan; Pineda, Elmor D
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Barcelona, Spain
Sustained Serum Neurofilament Light Chain Reduction With Long-Term Ocrelizumab Treatment in OPERA I and ORATORIO Trials and Their Open-Label Extensions in Relapsing and Primary Progressive MS
Kuhle, Jens; Thanei, Gian; Benkert, Pascal; Bar-Or, Amit; Cross, Anne H.; Kappos, Ludwig; Leppert, David; Herman, Ann; Jia, Xiaoming; Raposo, Catarina; Hauser, Stephen L.
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
07:26 AM
Duration 10mins Auditorium
Fenebrutinib maintains early and sustained low disease activity in patients with relapsing multiple sclerosis: 2-year results from the FENopta open-label extension
Oh, Jiwon; Drulovic, Jelena; Dufek, Michal; Budincevic, Hrvoje; Habek, Mario; Caunt, Maresa; Chen, Ying-Fang; Harp, Christoper; Sierzega, Malgorzata; Clayton, David; Ratchford, Jack; Goodyear, Alexandra; Bar-Or, Amit
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:35 AM
Duration 10mins Auditorium
Ocrelizumab vs Placebo in Primary Progressive MS: Efficacy and Safety Results of the Phase IIIb ORATORIO-HAND Study
Giovannoni, Gavin; Airas, Laura; Bove, Riley; Cutter, Gary; Hobart, Jeremy; Kuhle, Jens; Montalban, Xavier; Tur, Carmen; Wolinsky, Jerry S; Schneble, Hans-Martin; Baldinotti, Anna; Bonati, Ulrike; Giacobino, Caroline; Wang, Qing; Yang, Ke; Oh, Jiwon
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:45 AM
Duration 10mins Auditorium
Efficacy and Safety of a Body-Weight–Adjusted High Dose of Ocrelizumab vs Standard Dose in PPMS: Primary Results of the Phase IIIb GAVOTTE Study
Hauser, Stephen L.; Giovannoni, Gavin; Kappos, Ludwig; Oh, Jiwon; Bar-Or, Amit; Sormani, Maria Pia; Weber, Martin S.; Stoll, Sharon; Nicholas, Jacqueline A.; Nehrych, Tetyana; Bonek, Robert; Zecevic, Dusanka; Raposo, Catarina; Owen, Rebecca; Bonati, Ulrike; Madjar, Katrin; Wang, Qing; Raievska, Anastasiia; Schneble, Hans-Martin; Montalban, Xavier
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:55 AM
Duration 10mins Auditorium
Efficacy and Safety of Ocrelizumab Compared With Fingolimod in Paediatric Relapsing-Remitting MS: Results of the Phase III OPERETTA 2 Study
Banwell, Brenda; Kotulska, Katarzyna, Rostásy, Kevin; Deiva, Kumaran; Sato, Henry; Filippi, Massimo; Chitnis, Tanuja; Pia Sormani, Maria; Krupp, Lauren; Bar-Or, Amit; Evershed, Joanna; El Azzouzi, Bouchra; Wang, Qing; Lin, Chien-Ju; Hogea, Alexandra; Schneble, Hans-Martin; Manlius, Corinne; Waubant, Emmanuelle
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 10mins Barcelona, Spain
Long-term Effectiveness and Safety of Satralizumab▼ in a Real-world Clinical Setting in Japan for Neuromyelitis Optica Spectrum Disorder: A 2.5-year Final Analysis of Multicenter Medical Chart Review (the SAkuraBeyond Study)
Kazuo Fujihara, Noriko Isobe, Katsuichi Miyamoto, Masaaki Niino, Jin Nakahara, Satoshi Hattori, Masami Tanaka, Masayuki Tahara, Akio Suzumura, Kenzo Sakurai, Nobuaki Yoshikura, Kazutaka Shiomi, Hirofumi Ochi, Eiichiro Nagata, Kazushi Deguchi. Yuji Tomizawa, Katsuhisa Yamashita, Tadashi Nagatsuka, Hiroki Adachi, Ichiro Nakashima
Neuroscience | Neuromyelitis Optica Spectrum Disorder

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.